Sequent Scientific
Sequent Scientific Performance
Day Range
- Low
- High
52 Week Range
- Low
- High
- Open Price
- Previous Close
- Volume
Start SIP in Sequent Scientific
Start SIPSequent Scientific Investment Rating
-
Master Rating:
-
Sequent Scientific has an operating revenue of Rs. 1,420.91 Cr. on a trailing 12-month basis. An annual revenue de-growth of 0% needs improvement, Pre-tax margin of -10% needs improvement, ROE of -17% is poor and needs improvement. The company has a reasonable debt to equity of 26%, which signals a healthy balance sheet. The stock from a technical standpoint is trading below to its 200DMA and close to its 50DMA. It needs to take out the 200DMA levels and stay above it to make any further meaningful move. From an O'Neil Methodology perspective, the stock has an EPS Rank of 8 which is a POOR score indicating inconsistency in earnings, a RS Rating of 14 which is POOR indicating the underperformance as compared to other stocks, Buyer Demand at B which is evident from recent demand for the stock, Group Rank of 110 indicates it belongs to a poor industry group of Medical-Diversified and a Master Score of D is close to being the worst. Overall, the stock has poor technical strength and poor fundamentals, there are superior stocks in the current market environment.
EPS Strength
Price Strength
Buyer Demand
Group Rank
| Indicator | Mar 2023 | Dec 2022 | Sep 2022 | Jun 2022 | Mar 2022 |
|---|---|---|---|---|---|
| Oper Rev Qtr Cr | 47 | 57 | 54 | 65 | 64 |
| Operating Expenses Qtr Cr | 53 | 66 | 64 | 67 | 58 |
| Operating Profit Qtr Cr | -6 | -9 | -10 | -2 | 5 |
| Depreciation Qtr Cr | 2 | 2 | 2 | 2 | 2 |
| Interest Qtr Cr | 1 | 1 | 1 | 0 | 1 |
| Tax Qtr Cr | 0 | -3 | -2 | 0 | 1 |
| Net Profit Qtr Cr | -2 | -1 | -4 | 1 | 7 |
Sequent Scientific Technicals
EMA & SMA
- Bullish Moving Average
- ___
- 5
- Bearish Moving Average
- ___
- 11
- 20 Day
- ₹74.82
- 50 Day
- ₹75.21
- 100 Day
- ₹77.93
- 200 Day
- ₹88.9
- 20 Day
- ₹75.4
- 50 Day
- ₹74.85
- 100 Day
- ₹74.83
- 200 Day
- ₹87.56
Sequent Scientific Resistance and Support
| Resistance | |
|---|---|
| First Resistance | ₹76.54 |
| Second Resistance | ₹78.12 |
| Third Resistance | ₹79.34 |
| RSI | 49.86 |
| MFI | 45.47 |
| MACD Single Line | -0.46 |
| MACD | -0.61 |
| Support | |
|---|---|
| First Resistance | ₹73.74 |
| Second Resistance | ₹72.52 |
| Third Resistance | ₹70.94 |
Sequent Scientific Delivery and Volume
| Period | NSE + BSE Volume Avg | NSE + BSE Delivery Volume Avg | NSE + BSE Delivery Volume % |
|---|---|---|---|
| Day | 1,504,861 | 48,516,719 | 32.24 |
| Week | 886,953 | 33,491,360 | 37.76 |
| 1 Month | 1,765,847 | 47,465,960 | 26.88 |
| 6 Month | 2,106,511 | 44,763,354 | 21.25 |
Sequent Scientific Result Highlights
Sequent Scientific Synopsis
NSE-Medical-Diversified
Sequent Scientific is involved in the business activities of Manufacture of veterinary preparations. Company’s Total Operating Revenue is Rs. 222.69 Cr. and Equity Capital is Rs. 49.89 Cr. for the Year ended 31/03/2023. Sequent Scientific Ltd. is a Public Limited Listed company incorporated on 28/06/1985 and has its registered office in the State of Maharashtra, India. Company’s Corporate Identification Number(CIN) is L99999MH1985PLC036685 and registration number is 036685.| Market Cap | 1,852 |
| Sales | 223 |
| Shares in Float | 11.72 |
| No of funds | 45 |
| Yield |
| Book Value | 1.77 |
| U/D Vol ratio | 1.9 |
| LTDebt / Equity | |
| Alpha | -0.16 |
| Beta | 1.01 |
Sequent Scientific
| Owner Name | Mar-23 | Dec-22 | Sep-22 | Jun-22 |
|---|---|---|---|---|
| Promoters | 52.79% | 52.79% | 52.79% | 52.79% |
| Mutual Funds | 0.25% | 0.25% | 0.45% | 0.29% |
| Insurance Companies | 1.21% | 1.21% | 1.21% | |
| Foreign Portfolio Investors | 5.89% | 6.25% | 6.57% | 6.45% |
| Financial Institutions/ Banks | 0.01% | |||
| Individual Investors | 29.03% | 28.6% | 27.92% | 28.2% |
| Others | 10.83% | 10.9% | 11.05% | 12.27% |
Sequent Scientific Management
| Name | Designation |
|---|---|
| Dr. Kamal K Sharma | Chairman & Ind.Director |
| Mr. Rajaram Narayanan | Managing Director & CEO |
| Mr. Sharat Narasapur | Joint Managing Director |
| Mr. Gregory John Andrews | Non Executive Director |
| Mr. Neeraj Bharadwaj | Non Executive Director |
| Dr. Fabian Kausche | Non Executive Director |
| Mr. Rahul Mukim | Non Executive Director |
| Mr. Milind Sarwate | Independent Director |
| Dr.(Mrs.) Kausalya Santhanam | Independent Director |
Sequent Scientific Forecast
Price Estimates
Sequent Scientific Corporate Action
Sequent Scientific FAQs
What is Share Price of Sequent Scientific ?
Sequent Scientific share price is ₹74 As on 09 June, 2023 | 12:41
What is the Market Cap of Sequent Scientific ?
The Market Cap of Sequent Scientific is ₹1858.3 Cr As on 09 June, 2023 | 12:41
What is the P/E ratio of Sequent Scientific ?
The P/E ratio of Sequent Scientific is -15.5 As on 09 June, 2023 | 12:41
What is the PB ratio of Sequent Scientific ?
The PB ratio of Sequent Scientific is 2.5 As on 09 June, 2023 | 12:41